SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

AstraZeneca Pharma India informs about board meeting

14 Jan 2016 Evaluate

AstraZeneca Pharma India has informed that a meeting of the Board of Directors of the Company will be held on February 06, 2016, to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2015. Further the Trading Window shall remain closed for all Designated Persons, from December 16, 2015 to February 08, 2016 in terms of AstraZeneca Pharma India - Code of Conduct for Prevention of Insider Trading framed under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015.

The above information is a part of company’s filings submitted to BSE.

Astrazeneca Pharma I Share Price

8454.40 -65.40 (-0.77%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×